MOTS-c

MOTS-c is a 16 amino acid peptide encoded within mitochondrial DNA — specifically within the 12S ribosomal RNA gene. It is one of the first identified mitochondria-derived peptides (MDPs). MOTS-c acts as a metabolic regulator, improving insulin sensitivity, activating AMPK pathways, and enhancing cellular stress resistance.

MOTS-c activates AMPK (AMP-activated protein kinase), a master metabolic sensor that promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. It also inhibits the folate cycle and de novo purine synthesis, which shifts cellular metabolism toward fat oxidation. These effects improve insulin sensitivity independently of body weight changes.

Yes. Circulating MOTS-c levels significantly decline with age in humans. This decline correlates with age-related metabolic dysfunction, increased insulin resistance, and reduced physical performance. Exogenous MOTS-c administration in aged mice reverses these metabolic deficits and extends healthy lifespan — making it a significant target in longevity research.

Research shows MOTS-c enhances physical performance in mice by increasing muscle glucose uptake, improving mitochondrial function, and reducing fatigue. Exercising muscles naturally release MOTS-c into circulation, suggesting it is part of the body's exercise-induced signaling response. Exogenous MOTS-c amplifies these effects in preclinical models.

Epithalon works primarily through telomere elongation and pineal gland regulation. MOTS-c works through mitochondrial metabolic pathways — AMPK activation, insulin sensitivity, and cellular energy homeostasis. They target different aging mechanisms and may be complementary in a longevity protocol. MOTS-c has more robust metabolic data; epithalon has more longevity-focused human research from Khavinson et al.